Products for Research Use Only
RegisterLogin

HaloPROTAC-E

CAT: 0804-HY-145752-03Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-145752-03Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
HaloPROTAC-E is a potent Halo PROTAC degrader that reversibly induces degradation of two Halo-tagged endoplasmic reticulum-localized proteins, SGK3 and VPS34, with a DC50 of 3-10 nM. HaloPROTAC-E significantly and selectively induces degradation of endogenous VPS34 complexes (VPS34, VPS15, Beclin1, and ATG14) labeled with Halo and inhibits autophagy.
CAS Number
2365478-58-4
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Autophagy; PROTACs; SGK
Type
Reference compound
Related Pathways
Autophagy; Metabolic Enzyme/Protease; PROTAC
Applications
COVID-19-immunoregulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/haloprotac-e.html
Purity
98.76
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1(CC1)C#N)N[C@@H](C(C)(C)C)C(N(C[C@@H]2O)[C@@H](C2)C(NCC(C=CC(C(SC=N3)=C3C)=C4)=C4OCCOCCOCCOCCCCCCCl)=O)=O
Molecular Formula
C39H56ClN5O8S
Molecular Weight
790.41
Precautions
H315, H319, H335
References & Citations
[1]Tovell H, Testa A, Maniaci C, et al. Rapid and Reversible Knockdown of Endogenously Tagged Endosomal Proteins via an Optimized HaloPROTAC Degrader. ACS Chem Biol. 2019;14 (5) :882-892.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Chemical Information

HaloPROTAC-E
CAS Number2365478-58-4
PubChem CID154723985
IUPAC Name(2S,4R)-N-[[2-[2-[2-[2-(6-chlorohexoxy)ethoxy]ethoxy]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2S)-2-[(1-cyanocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxypyrrolidine-2-carboxamide
Molecular FormulaC39H56ClN5O8S
Molecular Weight790.4
XLogP4.1
Topological Polar Surface Area201
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count11
Rotatable Bond Count24
Heavy Atom Count54
Formal Charge0
Complexity1250
SMILES
CC1=C(SC=N1)C2=CC(=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)C4(CC4)C#N)O)OCCOCCOCCOCCCCCCCl
InChI
InChI=1S/C39H56ClN5O8S/c1-27-33(54-26-43-27)28-9-10-29(32(21-28)53-20-19-52-18-17-51-16-15-50-14-8-6-5-7-13-40)23-42-35(47)31-22-30(46)24-45(31)36(48)34(38(2,3)4)44-37(49)39(25-41)11-12-39/h9-10,21,26,30-31,34,46H,5-8,11-20,22-24H2,1-4H3,(H,42,47)(H,44,49)/t30-,31+,34-/m1/s1
InChIKey
NJCGXLMTZGCSRS-JSWXEYCZSA-N
Chemical Structure
2D Structure
2D structure of HaloPROTAC-E
CAS: 2365478-58-4
CID: 154723985
Formula: C39H56ClN5O8S
MW: 790.4
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight790.4
XLogP34.1
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count11
Rotatable Bond Count24
Exact Mass789.3538126
Monoisotopic Mass789.3538126
Topological Polar Surface Area201 Ų
Heavy Atom Count54
Formal Charge0
Complexity1250
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
HY-128978(E, E) -RAMB4
HY-Y0248-01(E, ​E) ​-​Farnesol
HY-114770(E, E) -GLL398
HY-N0007-01(E, E) -Bisdemethoxycurcumin
HY-W019710-01(E, E) -RGFP966
HY-131520(E, E, E) -Farnesyl alcohol azide
HY-N12873(E, E, E, ) -10,12,14-Hexadecatrienal
HY-Y0248R-01(E, E) -Farnesol (Standard)
HY-W749519(E, E) -Farnesol-13C3
HY-W654160E, E-Dienestrol-d6

Alternative Products

CatalogName
BA3644-1HaloPROTAC-E
A23918-50HaloPROTAC-E 50mg
A23918-5HaloPROTAC-E 5mg
A23918-10HaloPROTAC-E 10mg
A23918-1HaloPROTAC-E 1mg
A4652-10(E,E)-Bisdemethoxycurcumin
FB64958-01(E, E) -Bisdemethoxycurcumin
T12578-01(E, E) -RAMB4
TN7254-01(E, E) -Farnesol
447782-01E, E-Farnesylacetone

Popular Products